Thus, it is unclear whether to implicate or neglect the role of the given MTCH2 gene mutation in the progression of aggressive glioblastoma, in particular when the datasets assessed through cBioPortal included only those from primary tumor patients. Here, MTCH2 is linked to glioblastoma.